Some Important topics: Leukaemia, anemia, purpura, hodgkin lymphoma, thalassemia, sickle cell anemia, DIC, blood grouping. Everyone please study these topics now tomorrow I have exams on this topics teach ,e from Robbins

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Loading Image
Loading Image
Loading Image
All 8 topics are covered above. Here is a summary of what was taught and what to focus on tonight before your exam:

Your Exam Prep Summary - All 8 Topics from Robbins

What to focus on (high-yield for each topic):

1. Anemia - Classify by cause (blood loss / hemolysis / decreased production) and by MCV (micro/macro/normo). Know the clinical features of acute vs chronic anemia.
2. Sickle Cell Anemia - Autosomal recessive, Val→Glu substitution at β-globin position 6, HbS polymerizes when deoxygenated. Three modifying factors (HbF, HbA, MCHC). Complications = vaso-occlusion + hemolysis + functional asplenia. Protective against falciparum malaria.
3. Thalassemia - Quantitative defect in globin synthesis. β-thal = point mutations (chr 11); α-thal = deletions (chr 16). Know the 4-tier α-thalassemia spectrum. β-thal major = severe anemia + bone deformities + iron overload from transfusions.
4. Leukaemia - Know ALL (childhood, TdT+, BCR::ABL1 worst prognostic factor), CLL (CD5+ B cell, most common adult leukemia in West, BCL2 overexpression), AML (Auer rods, t(15;17) = APL = very favorable + ATRA sensitive + DIC risk).
5. Hodgkin Lymphoma - Reed-Sternberg cells (owl-eye nucleoli, CD15+/CD30+/CD45-). 5 subtypes: Nodular sclerosis is most common. EBV in ~70% of mixed cellularity. PD-L1 overexpression. Stepwise contiguous spread.
6. Purpura - ITP (IgG anti-platelet antibodies, splenectomy works in >2/3). TTP (pentad: FTMRN - Fever, Thrombocytopenia, Microangiopathic anemia, Renal failure, Neurological; ADAMTS13 deficiency). HIT (anti-PF4 antibody, causes thrombosis paradoxically).
7. DIC - Triggers: tissue factor release (sepsis, APL, obstetric) or endothelial injury. Dual picture: clotting AND bleeding. Labs: ↓platelets, ↓fibrinogen, ↑PT/aPTT, ↑D-dimers, schistocytes on smear.
8. Blood Grouping - ABO: O = universal donor (anti-A + anti-B), AB = universal recipient. ABO antibodies = IgM (naturally occurring). Rh: IgG, not naturally occurring, crosses placenta → HDN. Prevent with RhoGAM.
Good luck on your exam tomorrow! 🩸

Some Important topics: Leukaemia, anemia, purpura, hodgkin lymphoma, thalassemia, sickle cell anemia, DIC, blood grouping. Everyone please study these topics now tomorrow I have exams on this topics teach ,e from Robbins

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Loading Image
Loading Image
Loading Image
All 8 topics are fully covered above from Robbins. Here's your quick priority list for tonight's revision:

Tonight's Study Priority Order

1. DIC - Highest yield: know the 2 triggers (tissue factor release vs. endothelial injury), causes table (sepsis, APL, obstetric), the dual picture (clotting + bleeding), and the 6 lab findings. Study the pathophysiology diagram above.
2. Hodgkin Lymphoma - Know the Reed-Sternberg cell (owl-eye nucleoli, CD15⁺/CD30⁺/CD45⁻), the 5 subtypes (nodular sclerosis = most common), EBV association, PD-L1 immune evasion, and Ann Arbor staging.
3. Sickle Cell Anemia - Val→Glu at position 6 of β-globin, the 3 sickling factors, clinical complications (vaso-occlusion, functional asplenia, aplastic crisis), protective against malaria.
4. Thalassemia - The key table: β-thal (chr 11, point mutations; major/intermedia/minor) vs α-thal (chr 16, deletions; 1-2-3-4 gene deletions = silent/trait/HbH/hydrops). Pathophysiology of β-thal major (ineffective erythropoiesis → bone changes → iron overload).
5. Leukaemia - The 3 main types: ALL (children, TdT+, B-ALL vs T-ALL), CLL (CD5+, smudge cells, BCL2), AML (Auer rods, APL subtype t(15;17) = DIC risk + ATRA treatment).
6. Anemia - Classification by cause (hemorrhage/hemolysis/marrow failure) and by MCV (micro/macro/normo). Extravascular vs intravascular hemolysis differences.
7. Purpura - ITP (anti-platelet IgG, splenectomy works), TTP (FAT RN pentad, ADAMTS13 deficiency, plasma exchange), HIT (anti-PF4, paradoxical thrombosis).
8. Blood Grouping - ABO table (O = universal donor, AB = universal recipient), Rh system (IgG, not natural), HDN mechanism, and RhoGAM prevention.

For short notes

Here are your short notes for all 8 topics from Robbins - concise, exam-ready, and easy to memorize fast!

🩸 SHORT NOTES - HEMATOLOGY

(From Robbins Pathology)


1. ANEMIA

Definition: ↓ red cell mass → ↓ O₂ carrying capacity
3 Causes:
  • Blood loss (hemorrhage)
  • ↑ Destruction (hemolysis)
  • ↓ Production (marrow failure)
By MCV:
  • Microcytic → Iron deficiency / Thalassemia
  • Macrocytic → B12 / Folate deficiency
  • Normocytic → Spherocytosis / Sickle cell
Extravascular hemolysis: Jaundice + splenomegaly + gallstones, haptoglobin ↓ Intravascular hemolysis: Hemoglobinuria + hemosiderinuria + iron loss, haptoglobin ↓

2. SICKLE CELL ANEMIA

Gene: β-globin (chr 11) | Inheritance: Autosomal Recessive Mutation: Val replaces Glu at position 6 of β-globin → HbS
Pathogenesis:
  • Deoxygenation → HbS polymerizes → sickle shape
  • Reversible initially → repeated sickling → Ca²⁺ influx → irreversible sickled cells → hemolysis
3 Factors modifying severity:
  1. Other Hb levels (HbF/HbA inhibit polymerization)
  2. MCHC (↑ = worse)
  3. Transit time through microcirculation
Complications:
  • Vaso-occlusion → pain crises, stroke, acute chest
  • Hemolytic anemia + jaundice
  • Functional asplenia → susceptible to S. pneumoniae, H. influenzae
  • Aplastic crisis → Parvovirus B19
Protects against: Falciparum malaria Trait (HbAS): 40% HbS, 60% HbA → asymptomatic

3. THALASSEMIA

Definition: ↓ globin synthesis (quantitative) → Hb deficiency + excess chain precipitates
β-Thalassemiaα-Thalassemia
GeneChr 11Chr 16
Mutation typePoint mutationsGene deletions
β-Thalassemia:
  • Major (homozygous) → Severe anemia; transfusion-dependent
  • Intermedia → Moderate; transfusions not required
  • Minor (heterozygous) → Asymptomatic / mild
α-Thalassemia (1→2→3→4 gene deletions):
  • 1 gene → Silent carrier
  • 2 genes → Thal trait (mild)
  • 3 genes → HbH disease (moderate; β₄ tetramers)
  • 4 genes → Hydrops fetalis (lethal in utero; HbBart = γ₄)
β-Thal Major complications:
  • Erythroid hyperplasia → "Crew-cut" skull X-ray, chipmunk facies
  • Extramedullary hematopoiesis → hepatosplenomegaly
  • Transfusion iron overload → heart/liver/endocrine failure

4. LEUKAEMIA

ALL (Acute Lymphoblastic Leukemia)

  • Most common childhood cancer; B-ALL peak age 3 years
  • 85% B-ALL; T-ALL = adolescent males (thymic mass)
  • TdT⁺ (key marker)
  • B-ALL: CD10⁺ CD19⁺ | T-ALL: CD3⁺
  • Philadelphia chromosome t(9;22) → BCR::ABL1 = worst prognosis
  • 90% have chromosomal changes; most common = hyperploidy (>50 chr)

CLL/SLL (Chronic Lymphocytic Leukemia)

  • Most common adult leukemia (Western world)
  • CLL = blood lymphocytes >5000/µL
  • Indolent; BCL2 overexpression (chr 13q deletion)
  • CD5⁺ CD23⁺ B cell (key immunophenotype)
  • Morphology: Smudge cells + proliferation centers (pathognomonic)
  • Hypogammaglobulinemia; BTK signaling important

AML (Acute Myeloid Leukemia)

  • ≥20% blasts in marrow; peaks >60 yrs
  • Auer rods = pathognomonic (crystallized granules)
TranslocationSubtypePrognosisKey Fact
t(8;21)AMLFavorableAuer rods present
inv(16)AMLFavorableAbnormal eosinophils
t(15;17)APL (M3)Very favorableDIC risk; ATRA treatment
t(11q23)AMLPoorMonocytic

5. HODGKIN LYMPHOMA

Origin: Germinal center B cells Spread: Stepwise, contiguous (unlike NHL)

Reed-Sternberg Cell (MUST KNOW)

  • Size: 15-45 µm
  • "Owl-eye" nucleoli (large acidophilic, mirror-image lobes)
  • CD15⁺ CD30⁺ CD45⁻

5 Subtypes

Subtype%Key FeatureAge/Notes
Nodular Sclerosis70%Lacunar cells + collagen bandsYoung adults; mediastinal; BEST prognosis
Mixed Cellularity25%Classic RS cells; eosinophils; EBV 70%>50 yrs; M>F
Lymphocyte RichRareMany lymphocytes, rare RSGood
Lymphocyte DepletedRareMany RS, few lymphocytesElderly/HIV; WORST prognosis
NLPHL5%"Popcorn" L&H cells; CD20⁺ CD15⁻ CD30⁻Different biology
EBV: present in RS cells in 70% of mixed cellularity Immune evasion: ↑ PD-L1/PD-L2 → anti-PD-1 antibodies work Cytokines from RS: IL-5 (eosinophils), TGF-β (fibrosis), IL-13 (autocrine)
Ann Arbor Staging: I (1 node) → II (2+ nodes, same side) → III (both sides) → IV (disseminated) B symptoms: Fever + night sweats + weight loss >10% = worse prognosis

6. PURPURA

Petechiae <3 mm | Purpura 3-10 mm | Ecchymoses >1 cm

ITP (Immune Thrombocytopenic Purpura)

  • Chronic ITP: Women 20-40 yrs; autoimmune
  • Acute ITP: Children after viral infection; self-limited
  • IgG against platelet glycoproteins IIb/IIIa or Ib/IX
  • Spleen = Ab production site + platelet destruction site
  • Marrow: ↑ megakaryocytes
  • Symptoms: petechiae, epistaxis, gum bleed, easy bruising
  • Splenectomy → complete remission in >2/3 patients
  • NO splenomegaly in uncomplicated ITP

HIT (Heparin-Induced Thrombocytopenia)

  • 3-5% on unfractionated heparin after 1-2 weeks
  • IgG against platelet factor 4 (PF4) + heparin complex
  • Paradox: thrombocytopenia + THROMBOSIS
  • Treatment: Stop heparin → switch to direct thrombin inhibitors

TTP (Thrombotic Thrombocytopenic Purpura)

  • FAT RN pentad: Fever, microAngiopathic hemolytic anemia, Thrombocytopenia, Renal failure, Neurological symptoms
  • ADAMTS13 deficiency → ultra-large vWF multimers → platelet thrombi
  • Treatment: Plasma exchange

7. DIC (Disseminated Intravascular Coagulation)

Definition: Systemic coagulation activation → microthrombi everywhere → consumption of platelets/factors + secondary fibrinolysis
Dual consequence:
  • Thrombosis → ischemia/infarcts/microangiopathic hemolytic anemia
  • Bleeding → consumptive coagulopathy (factors + platelets used up)
2 Triggering mechanisms:
  1. Tissue factor release - obstetric (placenta), APL, cancer, sepsis (endotoxin → monocytes → IL-1/TNF)
  2. Endothelial injury - SLE, heat/burns, meningococci, rickettsiae
Causes (STOP MNT):
Sepsis | Trauma | Obstetric | Promyelocytic leukemia (APL) | Malignancy | Necrosis | Temperature extremes
Lab findings:
TestResult
Platelets
PT / aPTT
Fibrinogen
D-dimers
SmearSchistocytes
Organs hit most: Kidneys > Adrenals > Brain > Heart

8. BLOOD GROUPING

ABO System

GroupAntigenAntibodyDonate toReceive from
AAAnti-BA, ABA, O
BBAnti-AB, ABB, O
ABA+BNoneAB onlyAll (Universal Recipient)
ONoneAnti-A + Anti-BAll (Universal Donor)O only
  • ABO antibodies = naturally occurring IgM
  • Mismatch → acute intravascular hemolysis (life-threatening)

Rh System

  • RhD antigen: 85% Rh⁺, 15% Rh⁻
  • Rh antibodies = IgG (NOT naturally occurring; requires sensitization)
  • IgG = crosses placenta → HDN

HDN (Hemolytic Disease of Newborn)

Rh⁻ mother + Rh⁺ fetus
→ 1st pregnancy: sensitization (anti-RhD IgG forms at delivery)
→ 2nd Rh⁺ pregnancy: IgG crosses placenta → fetal RBC destruction
→ Hydrops fetalis / Kernicterus
Prevention: RhoGAM (Rh immune globulin) at 28 weeks + within 72 hrs of delivery

ONE-PAGE QUICK SUMMARY

TopicKey Fact 1Key Fact 2Key Fact 3
Anemia3 causes: loss/hemolysis/↓productionMicro=IDA/thal; Macro=B12/folateExtravascular: jaundice+splenomegaly
Sickle cellVal→Glu at β-globin pos.6; ARDeoxygenation → HbS polymerizesFunctional asplenia; protects vs malaria
Thalassemiaβ=chr 11 point mutations; α=chr 16 deletions4 α-gene deletions = hydrops fetalisβ-major: crew-cut skull + iron overload
LeukemiaALL = TdT⁺; most common childhood cancerCLL = CD5⁺; smudge cells; most common adultAML = Auer rods; APL = DIC + ATRA
HodgkinRS cells: owl-eye, CD15⁺ CD30⁺ CD45⁻Nodular sclerosis = most common subtypeEBV in 70% mixed cellularity
PurpuraITP = anti-IIb/IIIa IgG; splenectomy worksTTP = ADAMTS13 deficiency; plasma exchangeHIT = anti-PF4; paradoxical thrombosis
DICTrigger: tissue factor or endothelial injuryLabs: ↓Plat ↑PT/aPTT ↓Fibrinogen ↑D-dimerAPL (M3) = classic DIC-causing cancer
Blood groupO = universal donor; AB = universal recipientABO = IgM natural; Rh = IgG not naturalRhoGAM prevents HDN in Rh⁻ mothers

All sourced from Robbins & Kumar Basic Pathology + Robbins, Cotran & Kumar PBD Best of luck tomorrow! 🩸💪
This is a shared conversation. Sign in to Orris to start your own chat.